Cargando…

Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm

BACKGROUND: An animal model commonly used to investigate pathways and potential therapeutic interventions relevant to abdominal aortic aneurysm (AAA) involves subcutaneous infusion of angiotensin II within the apolipoprotein E deficient mouse. The aim of this study was to investigate genes different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rush, Catherine, Nyara, Moses, Moxon, Joseph V, Trollope, Alexandra, Cullen, Bradford, Golledge, Jonathan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728106/ https://www.ncbi.nlm.nih.gov/pubmed/19580648 http://dx.doi.org/10.1186/1471-2164-10-298

Ejemplares similares

Angiopoietin-2 attenuates angiotensin II-induced aortic aneurysm and atherosclerosis in apolipoprotein E-deficient mice
por: Yu, Hongyou, et al.
Publicado: (2016)

Effect of Hydralazine on Angiotensin II-Induced Abdominal Aortic Aneurysm in Apolipoprotein E-Deficient Mice
por: Wang, Yutang, et al.
Publicado: (2023)

Edaravone Attenuated Angiotensin II-Induced Atherosclerosis and Abdominal Aortic Aneurysms in Apolipoprotein E-Deficient Mice
por: Uchida, Haruhito A., et al.
Publicado: (2022)

Inhibition of angiotensin-induced aortic aneurysm by metformin in apolipoprotein E–deficient mice
por: Kunath, Anne, et al.
Publicado: (2021)

Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis
por: Krishna, Smriti Murali, et al.
Publicado: (2021)

Survival following abdominal aortic aneurysm repair in North Queensland is not associated with remoteness of place of residence
por: Golledge, Jonathan, et al.
Publicado: (2020)

The reproducibility of measuring maximum abdominal aortic aneurysm diameter from ultrasound images
por: Matthews, Evan O., et al.
Publicado: (2021)

Vitamin D deficiency promotes large rupture-prone abdominal aortic aneurysms and cholecalciferol supplementation limits progression of aneurysms in a mouse model
por: Nsengiyumva, Vianne, et al.
Publicado: (2020)

Association between aortic peak wall stress and rupture index with abdominal aortic aneurysm–related events
por: Singh, Tejas P., et al.
Publicado: (2023)

UCP-2 is involved in angiotensin-II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice
por: Yan, Peng, et al.
Publicado: (2017)

Pathogenesis and management of abdominal aortic aneurysm
por: Golledge, Jonathan, et al.
Publicado: (2023)

Flavonols reduce aortic atherosclerosis lesion area in apolipoprotein E deficient mice: A systematic review and meta-analysis
por: Phie, James, et al.
Publicado: (2017)

Deficiency of peroxiredoxin 2 exacerbates angiotensin II-induced abdominal aortic aneurysm
por: Jeong, Se-Jin, et al.
Publicado: (2020)

Osteopontin N-Terminal Function in an Abdominal Aortic Aneurysm From Apolipoprotein E-Deficient Mice
por: Liu, Hongyang, et al.
Publicado: (2021)

Systematic Review and Meta‐Analysis of Peak Wall Stress and Peak Wall Rupture Index in Ruptured and Asymptomatic Intact Abdominal Aortic Aneurysms
por: Singh, Tejas P., et al.
Publicado: (2021)

Colchicine Does Not Reduce Abdominal Aortic Aneurysm Growth in a Mouse Model
por: Phie, James, et al.
Publicado: (2022)

The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
por: Li, Jiaze, et al.
Publicado: (2016)

Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrate
por: Golledge, Jonathan, et al.
Publicado: (2020)

A Systematic Review of Studies Examining Inflammation Associated Cytokines in Human Abdominal Aortic Aneurysm Samples
por: Golledge, Alexandra L. V., et al.
Publicado: (2009)

Renal Denervation Promotes Atherosclerosis in Hypertensive Apolipoprotein E-Deficient Mice Infused with Angiotensin II
por: Wang, Yutang, et al.
Publicado: (2017)

Cohort Study Examining the Association of Optimal Blood Pressure Control at Entry With Infrarenal Abdominal Aortic Aneurysm Growth
por: Thomas Manapurathe, Diana, et al.
Publicado: (2022)

Recoupling of eNOS with Folic Acid Prevents Abdominal Aortic Aneurysm Formation in Angiotensin II-Infused Apolipoprotein E Null Mice
por: Siu, Kin Lung, et al.
Publicado: (2014)

Intravenous administration of mesenchymal stem cells prevents angiotensin II-induced aortic aneurysm formation in apolipoprotein E-deficient mouse
por: Fu, Xian-ming, et al.
Publicado: (2013)

Risk Factors and Mouse Models of Abdominal Aortic Aneurysm Rupture
por: Murali Krishna, Smriti, et al.
Publicado: (2020)

Interleukin-22 Deficiency Reduces Angiotensin II-Induced Aortic Dissection and Abdominal Aortic Aneurysm in ApoE-/- Mice
por: Wang, Yuan, et al.
Publicado: (2022)

Protocol for the Metformin Aneurysm Trial (MAT): a placebo-controlled randomised trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm
por: Golledge, Jonathan, et al.
Publicado: (2021)

Fenofibrate in the management of AbdoMinal aortic anEurysm (FAME): study protocol for a randomised controlled trial
por: Rowbotham, Sophie E., et al.
Publicado: (2017)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

Potential of Disease-Modifying Anti-Rheumatic Drugs to Limit Abdominal Aortic Aneurysm Growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)

Effects of Endogenous Angiotensin II on Abdominal Aortic Aneurysms and Atherosclerosis in Angiotensin II–Infused Mice
por: Kukida, Masayoshi, et al.
Publicado: (2021)

von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in mice
por: Portier, Irina, et al.
Publicado: (2018)

Cysteine-rich protein 2 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in mice
por: Chen, Chung-Huang, et al.
Publicado: (2022)

Systematic review and Meta-Analysis of Mendelian randomisation analyses of Abdominal aortic aneurysms
por: Ibrahim, Muhammad, et al.
Publicado: (2021)

Immunosuppressive drugs for nontransplant comorbidities are not associated with abdominal aortic aneurysm growth
por: Thanigaimani, Shivshankar, et al.
Publicado: (2022)

Calpain-2 Compensation Promotes Angiotensin II-Induced Ascending and Abdominal Aortic Aneurysms in Calpain-1 Deficient Mice
por: Subramanian, Venkateswaran, et al.
Publicado: (2013)

Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
por: Xu, Baohui, et al.
Publicado: (2021)

Growth of Screen-Detected Abdominal Aortic Aneurysms in Men: A Bayesian Analysis
por: Sherer, E A, et al.
Publicado: (2012)

Angiotensin II Type 1 Receptor Blocker Prevents Abdominal Aortic Aneurysm Progression in Osteoprotegerin‐Deficient Mice via Upregulation of Angiotensin (1–7)
por: Karasaki, Kohei, et al.
Publicado: (2023)

ADAM (a Disintegrin and Metalloproteinase) 15 Deficiency Exacerbates Ang II (Angiotensin II)–Induced Aortic Remodeling Leading to Abdominal Aortic Aneurysm
por: Jana, Sayantan, et al.
Publicado: (2020)

Differential gene expression in human abdominal aortic aneurysm and aortic occlusive disease
por: Biros, Erik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dr6lf09ujgfaqjmjrcsv4hsrcs